Pre Gestational Thalassemia Screening in Mainland China: The First Two Years of a Preventive Program

References

• Rund D. Thalassemia 2016: modern medicine battles an ancient disease. Am J Hematol. 2016;91(1):15–21.
   PubMed Web of Science ®Google Scholar
• Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480–487.
   PubMed Web of Science ®Google Scholar
• Li CK. New trend in the epidemiology of thalassaemia. Best Pract Res Clin Obstet Gynaecol. 2016;39:16–26.
   PubMed Web of Science ®Google Scholar
• Elborai Y, Uwumugambi A, Lehmann L. Hematopoietic stem cell transplantation for thalassemia. Immunotherapy. 2012;4(9):947–956.
   PubMed Web of Science ®Google Scholar
• Origa R. β-Thalassemia. Genet Med. 2016;19(6):609–619.
   PubMed Web of Science ®Google Scholar
• Leung WC, Leung KY, Lau ET, et al. α-Thalassaemia. Semin Fetal Neonatal Med. 2008;13(4):215–222.
   PubMed Web of Science ®Google Scholar
• Vichinsky EP. α Thalassemia major – new mutations, intrauterine management, and outcomes. Hematology Am Soc Hematol Educ Program. 2009:35–41.
   PubMedGoogle Scholar
• Dwinnell SJ, Coad S, Butler B, et al. In utero diagnosis and management of a fetus with homozygous α-thalassemia in the second trimester: a case report and literature review. J Pediatr Hematol Oncol. 2011;33(8):e358–e360.
   PubMed Web of Science ®Google Scholar
• Xiong F, Sun M, Zhang X, et al. Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China. Clin Genet. 2010;78(2):139–148.
   PubMed Web of Science ®Google Scholar
• Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of α and β thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol. 2004;57(5):517–522.
   PubMed Web of Science ®Google Scholar
• Liao C, Mo QH, Li J, et al. Carrier screening for α- and β-thalassemia in pregnancy: the results of an 11-year prospective program in Guangzhou Maternal and Neonatal Hospital. Prenat Diagn. 2005;25(2):163–171.
   PubMed Web of Science ®Google Scholar
• Li DZ, Li Y, Li J, et al. Prevention of Hb Bart’s (γ4) disease associated with the – –THAI α0-thalassemia deletion in Mainland China. Hemoglobin. 2015;39(6):412–414.
   PubMed Web of Science ®Google Scholar
• Chan V, Yam I, Chen FE, Chan TK. A reverse dot-blot method for rapid detection of non-deletion α thalassaemia. Br J Haematol. 1999;104(3):513–515.
   PubMed Web of Science ®Google Scholar
• He S, Li D, Lai Y, et al. Prenatal diagnosis of β-thalassemia in Guangxi Zhuang Autonomous Region, China. Arch Gynecol Obstet. 2014;289(1):61–65.
   PubMed Web of Science ®Google Scholar
• He S, Zhang Q, Li D, et al. Prevention and control of Hb Bart’s disease in Guangxi Zhuang Autonomous Region, China. Eur J Obstet Gynecol Reprod Biol. 2014;178:138–141.
   PubMed Web of Science ®Google Scholar
• Li J, Li R, Zhou JY, et al. Prenatal control of nondeletional α-thalassemia: first experience in mainland China. Prenat Diagn. 2013;33(9):869–872.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li DZ. Birth of children with severe β-thalassemia at a tertiary obstetric hospital: what are the reasons behind it? Prenat Diagn. 2013;33(11):1023–1026.
   PubMed Web of Science ®Google Scholar
• Liao C, Pan M, Han J, et al. Prenatal control of Hb Bart’s hydrops fetalis: a two-year experience at a mainland Chinese hospital. J Matern Fetal Neonatal Med. 2015;28(4):413–415.
   PubMed Web of Science ®Google Scholar
• National Health Service (NHS) Sickle Cell and Thalassaemia Screening Programme. Public health functions to be exercised by NHS England. 2013. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/256469/18_nns_sickle_cell_and_thalassaemia.pdf
   Google Scholar
• Li DZ. Premarital screening for thalassemia in mainland China. Prenat Diagn. 2009;29(6):637–638
   PubMed Web of Science ®Google Scholar
• Chen FE, Ooi C, Ha SY, et al. Genetic and clinical features of Hemoglobin H disease in Chinese patients. N Engl J Med. 2000;343(8):544–550.
   PubMed Web of Science ®Google Scholar
• Ma ES, Chow EY, Chan AY, Chan LC. Interaction between (– –SEA) α-thalassemia deletion and uncommon nondeletional α-globin gene mutations in Chinese patients. Haematologica. 2001;86(5):539–540.
   PubMed Web of Science ®Google Scholar
• Li DZ, Liao C. A case of transfusion-dependent nondeletional Hb H disease undiagnosed during prenatal screening for thalassemia. Prenat Diagn. 2008;28(2):165–166.
   PubMed Web of Science ®Google Scholar
• Lal A, Goldrich ML, Haines DA, et al. Heterogeneity of Hemoglobin H disease in childhood. N Engl J Med. 2011;364(8):710–718.
   PubMed Web of Science ®Google Scholar
• Tang HS, Zhou JY, Xie XM, Li DZ. Newborn screening for α-thalassaemia by a capillary electrophoresis method. J Med Screen. 2012;19(3):159.
   PubMed Web of Science ®Google Scholar
• Chan LC, Ma SK, Chan AY, et al. Should we screen for globin gene mutations in blood samples with mean corpuscular volume (MCV) greater than 80 fL in areas with a high prevalence of thalassaemia? J Clin Pathol. 2001;54(4):317–320.
   PubMed Web of Science ®Google Scholar
• Li J, Li R, Zhou JY, et al. Prenatal control of nondeletional α-thalassemia: first experience in mainland China. Prenat Diagn. 2013;33(9):869–872.
   PubMed Web of Science ®Google Scholar
• Liao C, Zhou JY, Xie XM, et al. Newborn screening for Hb H disease by determination of Hb Bart’s using the Sebia capillary electrophoresis system in southern China. Hemoglobin. 2014;38(1):73–75.
   PubMed Web of Science ®Google Scholar
• Xie XM, Zhou JY, Li J, et al. Implementation of newborn screening for Hemoglobin H disease in mainland china. Indian J Hematol Blood Transfus. 2015;31(2):242–246.
   PubMed Web of Science ®Google Scholar
• Yin XL, Zhang XH, Zhou TH, et al. Hemoglobin H disease in Guangxi Province, Southern China: clinical review of 357 patients. Acta Haematol. 2010;124(2):86–91.
   PubMed Web of Science ®Google Scholar
• Li J, Yan JM, Xie XM, et al. Consequences of delayed prenatal diagnosis of β-thalassemia in Mainland China. Hemoglobin. 2016;40(3):191–193.
   PubMed Web of Science ®Google Scholar
• He P, Yang Y, Li R, Li DZ. Prenatal control of Hb Bart’s disease in mainland China: can we do better? Hemoglobin. 2014;38(6):435–439.
   PubMed Web of Science ®Google Scholar
• Amato A, Cappabianca MP, Lerone M, et al. Carrier screening for inherited haemoglobin disorders among secondary school students and young adults in Latium, Italy. J Community Genet. 2014;5(3):265–268.
   PubMedGoogle Scholar
• Canatan D, Delibas S. Report on ten years’ experience of premarital hemoglobinopathy screening at a center in Antalya, Southern Turkey. Hemoglobin. 2016;40(4):273–276.
   PubMed Web of Science ®Google Scholar